Relationship between hand-foot skin reaction and external force on patients with hepatocellular carcinoma: A cohort study

被引:0
|
作者
Tahara, Yukie [1 ,3 ]
Amemiya, Ayumi [1 ]
Kase, Ryutaro [1 ]
Kitagawa, Yuka [1 ]
Ogasawara, Sadahisa [2 ]
Kato, Naoya [2 ]
Komiyama, Masatoshi [1 ]
机构
[1] Chiba Univ, Grad Sch Nursing, Dept Hlth Promot Nursing & Midwifery, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Gastroenterol, Chiba, Japan
[3] Chiba Univ, Grad Sch Nursing, Dept Nursing Physiol, 1-8-1 Inohana,Chuo Ku, Chiba, Chiba 2608672, Japan
关键词
Drug therapy; Hepatocellular carcinoma; Friction; Pressure; Hand-foot syndrome; SORAFENIB; REGORAFENIB; PREVENTION; LENVATINIB; EFFICACY; SAFETY; TRIAL; RISK;
D O I
10.1016/j.ejon.2024.102576
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Hand-foot skin reaction (HFSR), a side effect of tyrosine kinase inhibitor (TKI) treatment, makes it difficult to walk and perform daily activities because of pain in the limbs. HFSR occurs predominantly in the sites where external forces (pressure and shear stress) are applied. This study aimed to determine whether pressure or shear stress induces the occurrence of HFSR. Methods: This cohort study was conducted in patients who received TKI treatment for hepatocellular carcinoma. The external forces applied to the sole of the patients' foot while walking was measured, and its association with the occurrence of HFSR was examined. The degree of HFSR was assessed by the patient's response during the examination and by photographs of their feet. The patients' feet were divided into low (grade <2) or high (grade >= 2) HFSR foot group, and the differences in external forces between the groups were analyzed using t -test and Cox hazard analysis. Results: Analysis of the feet of 55 study participants (n = 110) showed no significant difference between the groups on t -test (p >= 0.05), however, Cox hazard analysis showed an increased risk of HFSR with higher peak shear stress values at the fifth metatarsal head (hazard ratio = 1.01, p = 0.047; 95% confidence interval = 1.00-1.02). Conclusion: Shear stress is possibly related to HFSR occurrence. Nurses should assess whether patients' shoes fit their feet before initiating TKI treatment. They should instruct patients to wear shoes that are fit of both diameter and width for their feet.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?
    Sibaud, V.
    Delord, J. P.
    Chevreau, C.
    TARGETED ONCOLOGY, 2009, 4 (04) : 307 - 310
  • [32] Sorafenib-induced hand-foot skin reaction: a Koebner phenomenon?
    V. Sibaud
    JP. Delord
    C. Chevreau
    Targeted Oncology, 2009, 4 : 307 - 310
  • [33] Preventive effect of celecoxib in sorafenib-related hand-foot syndrome in hepatocellular carcinoma patients, a single-center, open-label, randomized, controlled clinical phase III trial
    Chen, Jian-Cong
    Wang, Jun-Cheng
    Pan, Yang-Xun
    Yi, Min-Jiang
    Chen, Jin-Bin
    Wang, Xiao-Hui
    Fu, Yi-Zhen
    Zhang, Yao-Jun
    Xu, Li
    Chen, Min-Shan
    Zhang, Rong-Xin
    Zhou, Zhong-Guo
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (05): : 1467 - +
  • [34] Prophylactic strategies for hand-foot syndrome/skin reaction associated with systemic cancer treatment: a meta-analysis of randomized controlled trials
    Pandy, Jessa Gilda P.
    Franco, Paula Isabel G.
    Li, Rubi K.
    SUPPORTIVE CARE IN CANCER, 2022, 30 (11) : 8655 - 8666
  • [35] The Efficacy and Safety of the Shouzu Ning Decoction Treatment for Multi-Kinase Inhibitors-Associated Severe Hand-Foot Skin Reaction
    Shou, Liumei
    Shao, Tianyu
    Zhao, Fangmin
    Chen, Shuyi
    Chen, Qunwei
    Shu, Qijin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 45 - 53
  • [36] Severe hand-foot skin reaction and erythema multiforme-like lesions due to sorafenib
    Guliani, Ankur
    Daroach, Manju
    Aggarwal, Divya
    Radotra, Bishan Dass
    Kumaran, Muthu Sendhil
    POSTGRADUATE MEDICAL JOURNAL, 2018, 94 (1115) : 535 - 536
  • [37] Regorafenib-associated hand-foot skin reaction: practical advice on diagnosis, prevention, and management
    McLellan, B.
    Ciardiello, F.
    Lacouture, M. E.
    Segaert, S.
    Van Cutsem, E.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2017 - 2026
  • [38] Risk of hand-foot skin reaction with the novel multikinase inhibitor regorafenib: a meta-analysis
    Viswanath Reddy Belum
    Shenhong Wu
    Mario E. Lacouture
    Investigational New Drugs, 2013, 31 : 1078 - 1086
  • [39] The Hand-Foot Skin Reaction and Quality of Life Questionnaire: An Assessment Tool for Oncology
    Anderson, Roger T.
    Keating, Karen N.
    Doll, Helen A.
    Camacho, Fabian
    ONCOLOGIST, 2015, 20 (07) : 831 - 838
  • [40] Hand-Foot Skin Reaction with Sunitinib: A Rare Case Report with Review of Literature
    Das, Suchibrata
    Roy, Alok K.
    Barman, Srutee
    Roy, Aritra
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (06) : 522 - 525